Angela Garrard
Psychiatric/Mental Health · Gadsden, ALNPI 1770981458
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 925 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 925 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Tris Pharma Inc$1K
- plus $5K from 20 others
What the payments were for
- Food & beverage$14,40899%
- Education$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 116 | $2,256 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 144 | $2,125 |
| AbbVie | 106 | $1,414 |
| Alkermes, Inc. | 76 | $1,339 |
| Otsuka America Pharmaceutical, Inc. | 78 | $1,273 |
| Tris Pharma Inc | 76 | $1,075 |
| Ironshore Pharmaceuticals Inc. | 71 | $893 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $838 |
| Corium, LLC | 53 | $765 |
| Lundbeck LLC | 36 | $593 |
| Axsome Therapeutics, Inc. | 35 | $477 |
| Johnson & Johnson | 12 | $208 |
| Idorsia Pharmaceuticals US Inc | 11 | $164 |
| Neos Therapeutics, LP | 9 | $158 |
| Almatica Pharma LLC | 9 | $151 |
| E.r. Squibb & Sons, L.L.C. | 8 | $147 |
| Teva Pharmaceuticals USA, Inc. | 6 | $126 |
| Collegium Pharmaceutical, Inc. | 7 | $111 |
| Vertical Pharmaceuticals, LLC | 5 | $84 |
| Adlon Therapeutics L.p. | 5 | $69 |
| Noven Therapeutics, LLC | 3 | $66 |
| Eisai Inc. | 4 | $65 |
| Merck | 2 | $39 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$169
How this compares
$14,489 in reported general payments places this provider in the 95th percentile of 378 psychiatric/mental health providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 23 | $38,505 |
| Abilify MaintenaAripiprazole | 11 | $34,372 |
| RexultiBrexpiprazole | 14 | $19,822 |
| Trazodone Hcl | 98 | $2,569 |
| Divalproex Sodium ErDivalproex Sodium | 25 | $2,145 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $1,985 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 53 | $1,505 |
| Aripiprazole | 47 | $1,486 |
| Olanzapine | 54 | $1,329 |
| Duloxetine Hcl | 38 | $1,248 |
| Risperidone | 56 | $1,207 |
| Ziprasidone Hcl | 17 | $893 |
| Bupropion XlBupropion Hcl | 31 | $879 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $784 |
| Clonazepam | 73 | $651 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $1,273 | $54,19425 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,125 | $38,50523 claims |
| Almatica Pharma LLCSertraline Hcl | $151 | $31323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 378 psychiatric/mental health providers in Alabama.
Other psychiatric/mental health in Gadsden
- Taylor BarrettGadsden$15K
- Laura GrahamMontgomery$80K
- Yuliya SpencerBirmingham$65K
- Keri BarrBay Minette$35K
- John HayesMobile$30K
- Logan ThrasherHoover$22K
- Anthony PhillipsHelena$15K
- Ian KinzerHuntsville$15K
- Latisha AliHoover$15K
- Hunter HutchisonMontgomery$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.